Clinical

An expert panel discusses cost burden associated with the treatment of MS.

The findings, which suggest that axicabtagene ciloleucel (axi-cel) may be a good option for a patient group often deemed ineligible for other curative-intent therapy, come from a planned subgroup analysis from the ZUMA-7 trial.

Scientists have found a new therapy for the severe inflammatory skin disorder.

At a median follow-up of 10.7 months, the overall response rate was 63.1%.

Future myasthenia gravis therapies have different mechanisms of action than current treatments, said James F. Howard Jr, MD, professor of neurology at the University of North Carolina at Chapel Hill.

There was no difference in second primary cancer risk among older adult male patients treated with intensity-modulated radiotherapy (IMRT) vs 3-dimensional conformal radiation therapy for prostate cancer.

Glofitamab is the first bispecific antibody with a fixed-duration treatment for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

The treatment landscape for multiple myeloma has shifted since European Organisation for Research and Treatment of Cancer Quality of Life Multiple Myeloma Questionnaire (EORTC QLQ-MY20) was first developed in 1996.

A second study will evaluate the treatment and financial burden and quality of life of a program of subcutaneous daratumumab administered at home.

Randomized controlled trials had lower rates of success, but microbiota restoration still out-performed antibiotics.

The panelists provide their final thoughts regarding disparities in women’s health.

Misdiagnosis was common in these patients, and mean time to diagnosis was around 5 years.

Project CARA, a perinatal substance exposure clinic, has implemented a contingency management program that targets appointment attendance for patients with any use disorder, regardless of substance or urine drug screen results.

However, overall fertility rates of patients with psoriasis were similar to national fertility trends, authors found.

The study also highlighted disparities in accurate diagnosis of myelodysplastic syndromes (MDS).

The treatment landscape for HIV is discussed by a panel led by Dr Welch.

Key opinion leaders discuss the influence of guideline-directed therapy in the treatment of patients with HIV.

Both genera and regional anesthesia can be safely used in patients with pulmonary arterial hypertension (PAH).

The 68-year-old patient had multiple myeloma and breast cancer.

The incidence rate of melanoma in situ (MIS) has sharply risen since 1975.

Vaccine hesitancy is a significant barrier to optimal RSV vaccine rollout.

Experts discuss strategies to prepare for the oncoming respiratory diseases season.

Dr Filer highlights the considerations for the rollout of new RSV vaccines.

The pathophysiology and treatment of active and inactive MS are explored.

Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis.